A phase I study of paclitaxel, topotecan, cisplatin and Filgrastim in patients with newly diagnosed advanced ovarian epithelial malignancies: A Gynecologic Oncology group study

OBJECTIVES: To determine a recommended dose level (RDL) of paclitaxel, cisplatin and topotecan in women with previously untreated epithelial ovarian or peritoneal cancer as a possible experimental arm in a future Gynecologic Oncology Group phase III study. METHODS: Patients with newly diagnosed stag...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Armstrong, Deborah K., Bookman, Michael A., McGuire, William, Bristow, Robert E., Schilder, Jeanne M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2007
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC1987371/
https://ncbi.nlm.nih.gov/pubmed/17368526
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2007.01.039
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia